New Combination of Targeted Therapeutics Approved For Melanoma
Last week, the U.S. Food and Drug Administration (FDA) approved the use of cobimetinib (Cotellic) in combination with vemurafenib...
Last week, the U.S. Food and Drug Administration (FDA) approved the use of cobimetinib (Cotellic) in combination with vemurafenib...
The flurry of anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) late last month included the...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a first-of-its kind immunotherapeutic, talimogene laherparepvec or T-Vec...
Yesterday, Onivyde, which is a nanotherapeutic form of the conventional chemotherapeutic irinotecan, was approved by the U.S. Food and...
Late last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
Earlier this week, new ground was broken in the field of cancer immunotherapy when the U.S. Food and Drug...
Last week, the U.S. Food and Drug Administration (FDA) approved a new combination of drugs, formulated together in a...
Today, the American Association for Cancer Research (AACR) released the results of a national survey on American voter’s opinions...
Guest Post by Kelvin Lee, MD Roswell Park Cancer Institute